Aurora Cannabis (ACB) Short-term Investments (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Short-term Investments of $38.1 million for Q1 2026, up 1.94% on a QoQ basis from $37.4 million in Q4 2025.
Aurora Cannabis (ACB) Short-term Investments (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Short-term Investments for 9 consecutive years, with $38.1 million the latest figure, recorded in Q1 2026.
- Quarterly Short-term Investments changed N/A year-over-year to $38.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.1 million (changed N/A YoY) and the FY2026 annual result came in at $37.8 million, changed N/A from the prior year.
- Short-term Investments advanced to $38.1 million in Q1 2026 per ACB's latest filing, from $37.4 million in the prior quarter.
- Over the last five years, Short-term Investments for ACB reached as high as $66.7 million in Q2 2024 and fell as low as $564006.0 in Q1 2024.
- A 5-year average of $35.4 million and a median of $37.4 million in 2025 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2022 — Short-term Investments plunged 57.33% — and 2023, when it surged 164.23%.
- Year by year, Short-term Investments stood at $16.9 million in 2022, then jumped by 164.23% to $44.5 million in 2023, then climbed by 14.88% to $51.2 million in 2024, then decreased by 26.99% to $37.4 million in 2025, then increased by 1.94% to $38.1 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $38.1 million, $37.4 million, and $33.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.07 Mn |
| Dec 31, 2025 | 37.35 Mn |
| Sep 30, 2025 | 33.61 Mn |
| Jun 30, 2025 | 33.11 Mn |
| Dec 31, 2024 | 51.16 Mn |
| Sep 30, 2024 | 48.88 Mn |
| Jun 30, 2024 | 66.68 Mn |
| Mar 31, 2024 | 564,006.04 |
| Dec 31, 2023 | 44.53 Mn |
| Sep 30, 2023 | 47.66 Mn |
| Jun 30, 2023 | 48.88 Mn |
| Dec 31, 2022 | 16.85 Mn |
| Sep 30, 2022 | 19.64 Mn |
| Jun 30, 2022 | 20.61 Mn |
| Mar 31, 2022 | 23.48 Mn |
| Dec 31, 2021 | 29.14 Mn |
| Sep 30, 2021 | 33.75 Mn |
| Jun 30, 2021 | 48.31 Mn |
| Mar 31, 2021 | 49.87 Mn |
| Dec 31, 2020 | 36.33 Mn |